pfizer glp 1 drug Pfizer's Appetite for More Obesity Meds Leads to $150M Deal for Oral GLP-1 From China What the NY Times Got
Description
Oxyntomodulin Identified as a Marker of Type 2 Diabetes and Gastric Bypass Surgery by Mass-Spectrometry Based Profiling of Human Plasma
Disclaimer: This article is for educational purposes only and is not a substitute for medical advice
Endocrinology 144 , 51495158 (2003)
Genovese S, Mannucci E, Ceriello A
